Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Cell Death and Differentiation|October 12, 2019
LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursorsDiana Corallo, Michael Donadon, Marcella Pantile, et al.Bioorganic Chemistry|October 12, 2024
First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivoJaka Dernovšek, Dunja Urbančič, Živa Zajec, et al.Ecotoxicology and Environmental Safety|March 29, 2026
Comparative analysis of four PFAS regarding their toxicity to zebrafish developmentBenjamin Natha, Raimund Widhalm, Sebastian Granitzer, et al.Development (Cambridge, England)|February 25, 2018
Microbiota promote secretory cell determination in the intestinal epithelium by modulating host Notch signalingJoshua V Troll, M Kristina Hamilton, Melissa L Abel, et al.Blood|December 4, 2024
BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responsesGiulio Abagnale, Raphaela Schwentner, Philipp Ben Soussia-Weiss, et al.British Journal of Cancer|December 14, 2025
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancerBüsra Ernhofer, Anna Solta, Julia Sinner, et al.EMBO Molecular Medicine|January 3, 2026
Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcomaVeveeyan Suresh, Christoph Hafemeister, Andri Konstantinou, et al.Molecular Oncology|December 23, 2022
YB-1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2Karin Schelch, Sebastian Eder, Benjamin Zitta, et al.Cell Death and Differentiation|March 9, 2018
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatmentJing Shen, Sara Najafi, Sina Stäble, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 18, 2024
Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potencyJaka Dernovšek, Živa Zajec, Goran Poje, et al.Pageof 8